High level association of mutation in KatG315 with MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus

Acta Microbiologica et Immunologica Hungarica

Volumn 56, Issue 4, 2009, Pages 313-325

  Setareh, M ^a,b   Titov, L ^c   Surkova, L ^d  

^a BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Research Institute for Epidemiology & Microbiology RIEM   (Belarus)

^d Pulmonology Institute   (Belarus)

Author keywords

KatG315; Mycobacterium tuberculosis; PCR RFLP; Sequence

Indexed keywords

ETHAMBUTOL; ISONIAZID; KATG PROTEIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BELARUS; CODON; CONTROLLED STUDY; DRUG SENSITIVITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

MYCOBACTERIUM TUBERCULOSIS;

EID: 75149126934     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.56.2009.4.2     Document Type: Article

References (30)

1. Arnold, C.: Molecular evolution of Mycobacterium tuberculosis. Clin. Microbiol. Infect. 13, 120-128 (2007).
2. Brosch, R., Gordon, S., Marmiesse, M. et al.: A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99, 3684-3689 (2002).
3. Palomino, J. C. S., Cardoso, L., Ritacco, V. (eds): Tuberculosis 2007, From Basic Science to Patient Care; www.TuberculosisTextbook.com.
4. Filliol, I., Motiwala, A., Cavatore, M. et al.: Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 188, 759-772 (2006).
5. Zaleskis, R., Negru, M. L.: Fact Sheet EURO/02/07. Tuberculosis, WHO-Europa, Geneva, Berlin, Copenhagen, 22 March 2007. http://www.euro.who.int/ Document/Mediacentre/ fs0207e.pdf
6. Zaker, S. B., Titov, L. P., Slizen, V. V., Taghikhani, M., Bahremand, A.: katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients, Tuberkuloz ve Toraks Dergisi. 55, 231-237 (2007).
7. Zakerbostanabad, S., Titovb, L. P., Bahrmanda, A. R.: Frequency and molecular characterization of isoniazid resistance in katG region of MDR isolates from tuberculosis patients in southern endemic border of Iran. Infect. Genet. Evol. 8, 15-19 (2008).
8. Soolingen, V. D., Haas, P. E., Doorn, H. R., Kuijper, E., Rinder, H., Borgdorff, M. W.: Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 182, 1788-1790 (2000).
9. Sreevatsan, S., Pan, X., Stockbauer, K. et al.: Restricted gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94, 9869-9874 (1997).
10. World Health Organisation 1998. Laboratory services in tuberculosis control. Part III. Culture, p. 77.
11. Piatek, A. S., Telenti, A., Murray, M. R.: Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44, 103-110 (2000).
12. Mokrousov, I., Otten, T., Filipenko, M.: High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 46, 1417-1424 (2002).
13. Dobner, P., Rusch-Gerdes, S., Bretzel, G., Feldmann, K., Rifai, M., Loscher, T., Rinder, H.: Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 1, 365-369 (1997).
14. Victor, T. C., Pretorius, G. S., Felix, J. V., Jordaan, A. M., van Helden, P. D., Eisenach, K. D.: katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent. Antimicrob. Agents Chemother. 40, 1572 (1996).
15. Haas, W. H., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, R. B., Bretzel, G., Sticht-Groh, V., Bremer, H. J.: Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents Chemother. 41, 1601-1603 (1997).
16. Kiepiela, P., Bishop, K. S.: Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung Dis. 80, 47-56 (2000).
17. Leung, E. T. Y., Kam, K. M., Chiu, A., Leung, P. H., Seto, W. H., Yuen, K. Y., Yam, W. C.: Detection of KatGSer315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J. Med. Microbiol. 52, 999-1003 (2003).
18. Escalante, P., Ramaswamy, S., Sanabria, H., Soini, H., Pan, X., Valiente-Castillo, O., Musser, J. M.: Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuberc. Lung Dis. 79, 111-118 (1998). (Pubitemid 29078280)
19. Marttila, H. J., Marttila, H. J., Soini, H., Eerola, E., Vyshnevskaya, E., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., Viljanen, M. K.: A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother. 42, 2443-2445 (1998).
20. Rouse, D. A.: Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39, 2472-2477 (1995).
21. Tracevska, T. J.: Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. Clin Microbiol. 40, 3789-3792 (2002).
22. Silva, M. S. N.: Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41, 4471-4474 (2003).
23. Sekiguchi, J.: Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45, 179-192 (2007).
24. Ano, H., Matsumoto, T., Suetake, T.: Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan. Int. J. Tuberc. Lung Dis. 12, 1300-1305 (2008).
25. Tavakoli, A., Mohajeri, P., Shojaei, H.: Study of mutations associated with isoniazid-resistance in clinical Mycobacterium tuberculosis strains, Tehran and Isfahan Province Tuberculosis Centers by Pcr and Rflp-based technique (2004-2005). Behbood 11, 266-276 (2007).
26. Sajduda, A.: Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42, 2425-2431 (2004). (Pubitemid 38747484)
27. Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., Wong, S. Y.: Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43, 2087-2089 (1999).
28. Piatek, A.S., Telenti, A., Murray, M. R.: Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44, 103-110 (2000).
29. Walsh, P. S., Metzger, D. A., Higuchi, R.: Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10, 506-513 (1991).
30. Nguyen, L., Thompson, C. J.: Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol. Jul. 14, 304-312 (2006).